ArticleFrontiers in research metrics and analytics2023
The political economy of the African pharmaceutical sector's "industrial underdevelopment" lock-in: The importance of understanding the impact of persistent colonial extractive institutions.
Article in Frontiers in research metrics and analytics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Strengthening Biomedical Research and Healthcare in Africa Through Localized Reagent Production.BioMed research international · 2026Review
- Decolonizing global health: Africa's pursuit of pharmaceutical sovereignty.BMC health services research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improved African pharmaceutical manufacturing has been on global and local agendas since the 1970s, yet the industry has been locked-in into low technologies for decades. What caused the technological and industrial stagnation for such a critical sector for local and global health security? What are the political economy roots of such long-running industrial underdevelopment lock-in? What do colonial extractive economic and political institutions and their setup and mixes have to do with the sector? This study considers how extractive economic and political institutions' architectures and infrastructures shaped the African pharmaceutical industry's underdevelopment. We argue that extractive economic and political institutions shaped contemporary institutions in former colonial countries, and these institutions persist for a long time. The pivotal argument of innovation systems is that technological change-driven innovation is important for building superior economic performance and competitiveness, and institutions are a vital component of the system. However, institutions are not value-neutral; they carry the political and economic objectives and aspirations of the agents who design them. Innovation systems theory needs to incorporate the analysis of extractive economic and political institutions and the role they played in locking-in the African pharmaceutical industries into underdevelopment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.